RecruitingNCT06643741
Non-Invasive Preeclampsia Screening and Biobank
Collection of Pregnancy Outcome Data and Whole Blood Samples From Women Undergoing Non-Invasive Screening for Early, Preterm, and Term Preeclampsia
Sponsor
Sequenom, Inc.
Enrollment
6,550 participants
Start Date
Feb 2, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Women pregnant between 11-14 weeks gestation will be enrolled with blood samples collected to evaluate for preeclampsia.
Eligibility
Sex: FEMALEMin Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is collecting blood samples and health data from pregnant women in their first trimester to develop and validate better non-invasive tests for predicting preeclampsia (a dangerous complication of pregnancy involving high blood pressure).
**You may be eligible if...**
- You are female and 18 years or older
- You are between 11 and 14 weeks pregnant with a single baby
- You agree to blood draws at each trimester and to share your prenatal and postnatal health data
- You are willing to have specific measurements taken at your routine first-trimester ultrasound
**You may NOT be eligible if...**
- You are unlikely to return for second and third trimester visits
- Your pregnancy outcome data is unlikely to be available
- You are already enrolled in a study involving aspirin or taking unknown doses of aspirin
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(21)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06643741
Related Trials
Validation of the MaiRa Preeclampsia Test for Screening Early/Late Preeclampsia in First and Second Trimesters
NCT0671624211 locations
Cardiometabolic Disease and Substrate Metabolism
NCT075657271 location
Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
NCT029890251 location
The Combined First Trimester Screening
NCT070152033 locations
Preeclampsia: Origin, Characteristics and Effects on Mother and Baby
NCT075135581 location